Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Knowing when to opt for index funds over stocks helps you prioritize diversification and lower maintenance while pursuing gains.
25,835 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Oil prices surged after ships halted near Hormuz amid Iranian warnings, signaling a potential energy shock for househ...
Hedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...
A stock delivering a 7% dividend yield and yet slipping 20% year-to-date may seem puzzling. This guide explains how t...
Credit investors are increasingly worried about an AI bubble. A Bank of America survey shows the concern rising fast,...
Bitcoin slid to a two-week low near $78,000 after a brief run to the mid-80s, throwing cold water on a quick bear-mar...
For years, SK Hynix has traded at a discount to Micron. This article explains why the gap exists, what could close it...
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
Hive Digital Technologies jumped 34% and T1 Energy rose 20% as traders chased chatter around Leopold Aschenbrenner’s ...
The United States still holds a 714-million-barrel strategic reserve capacity, a focal point for policy debates and e...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
June brought a dramatic shift in Bitcoin ETF flows, but that doesn’t spell doom for the crypto thesis. This guide exp...